Searched for
CYTOTOXIC
How to identify Gaboon Viper: Key physical features, range, habitat, and dietAfrica's Gaboon viper boasts the longest fangs of any venomous snake. This master of camouflage lives in forests and is a patient hunter. W...- Why Experts Say Vinegar and Hydrogen Peroxide Clean Better Together – And the Safe Way to Use ThemDiscover a powerful cleaning duo for your home. Vinegar and hydrogen peroxide, when used one after another, offer an effective and eco-frie...
- New drugs could reach market sooner as govt halves trial review timelineThe Indian government is shaking up the pharmaceutical sector by slashing the review period for manufacturing applications for new drugs to...
- Fundamental Radar: Why is Beta Drugs a good play in the oncology space? Sandeep Raina explainsBeta Drugs is well placed to capitalise on the growth opportunities in the oncology drugs segment, aided by its comprehensive product portf...
- Scientists from India, Russia, Brazil, South Africa will collaborate on Covid researchThe consolidation of efforts, knowledge and experience of scientists and specialists from different areas will lead to the optimisation of ...
- Sun Pharma gets USFDA nod for cancer treatment injectionThe approval from the USFDA is for INFUGEM injection (gemcitabine in 0.9 per cent sodium chloride injection) 10 mg/mL, for intravenous use ...
- USFDA accepts Mylan's BLA for proposed biosimilar PegfilgrastimThe proposed biosimilar Pegfilgrastim is one of the six biologic products co-developed by Mylan and Biocon for the global marketplace, the ...
- Cobra venom can help surgeons see boundaries of cancerMoscow, Dec 9 (IANS) In collaboration with researchers from Assam's Tezpur University, Russian scientists have developed a substance-based ...
- Blood protein paves way for potential Alzheimer's drug designKolkata, Dec 9 (IANS) Opening up new horizons in designing drugs for Alzheimer's disease, Indian researchers have discovered that fibrinoge...
- Natural compound in onions may help fight ovarian cancerIt has a relatively low lifetime risk that is less than one per cent, but that can increase up to 40 per cent if there is a family history.
- Sun launches ready-to-administer chemotherapy drugSun Pharma said Gemcitabine InfuSMART is the world’s first licensed RTA product, which was developed by its R&D team in India.
- Sun Pharma starts rollout of Gemcitabine InfuSMART in six European nationsGemcitabine is indicated in the treatment of ovarian, lung, breast and pancreatic cancer. Sun Pharma hinted at more oncology products being...
- Reliance Life Sciences gets US FDA nod for Navi Mumbai plantReliance Life Sciences has received approval from the US drug regulator for its active pharmaceutical ingredient (API) manufacturing facili...
- Protein that boosts immunity to viruses and cancer foundResearchers from Imperial College London and colleagues in experiments in mice and human cells found that the protein promotes the prolifer...
- New compound may treat HIV, drug-resistant TBResearchers, including one of Indian-origin, have developed a new molecule that may treat multi-drug resistant tuberculosis and even HIV in...
- Existing drug may treat deadly form of malariaA drug already approved for treating other diseases in humans may be useful as a treatment for deadly cerebral malaria, according to Harvar...
- Dr Reddy's Laboratories may spend Rs 1,000 cr on capex next fiscalDRL is set to invest more than Rs 1,000 crore on capital expenditure in the next financial year, a top executive of the pharma major said h...
- Roselabs invests Rs 400 crore to set up syringes plantRoselabs Group firms today said the group has invested over Rs 400 crore to set up a pre-filled syringes making facility
- Dishman to chase high-potency therapiesDishman Pharmaceuticals Ltd, will now focus on the high-potency therapies like steroids, hormones, isotopes and cytotoxics.
- Hospira-Mayne deal likely to alter pharma equations hereOne of the biggest trans-continent deals in the generic pharma sector is likely open the floodgates of opportunities for the Indian pharma ...
Load More
